ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 171 filers reported holding ARRAY BIOPHARMA INC in Q4 2016. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $816,000 | -63.3% | 50,000 | -81.2% | 0.48% | -45.4% |
Q2 2017 | $2,223,000 | +11.5% | 265,589 | +19.1% | 0.88% | +49.7% |
Q1 2017 | $1,994,000 | +44.2% | 223,000 | +41.7% | 0.59% | +16.4% |
Q4 2016 | $1,383,000 | +581.3% | 157,360 | +424.5% | 0.51% | +717.7% |
Q3 2016 | $203,000 | – | 30,000 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 17,850,650 | $75,330,000 | 5.64% |
BVF INC/IL | 6,682,711 | $28,201,000 | 4.81% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 8,729,361 | $36,838,000 | 1.49% |
First Light Asset Management, LLC | 530,391 | $2,238,000 | 0.94% |
KOPP INVESTMENT ADVISORS LLC | 376,477 | $1,589,000 | 0.78% |
Sarissa Capital Management LP | 700,000 | $2,954,000 | 0.57% |
Orbimed Advisors | 10,689,000 | $45,108,000 | 0.41% |
Bedell Frazier Investment Counselling, LLC | 178,971 | $755,000 | 0.37% |
PINNACLE ASSOCIATES LTD | 3,453,487 | $14,574,000 | 0.31% |
Artal Group S.A. | 3,710,000 | $15,656,000 | 0.29% |